outcome

Failure of natalizumab to prevent relapses in neuromyelitis optica.

Kleiter I, Hellwig K, Berthele A, Kümpfel T, Linker RA, Hartung H-P, et al.. Failure of natalizumab to prevent relapses in neuromyelitis optica. Archives Neurology. 2012;69(2):239-45. DOI: 10.1001/archneurol.2011.216. PubMed PMID: 22332191.

Cerebrospinal fluid Aβ and tau level fluctuation in an older clinical cohort.

Moghekar A, Goh J, Li M, Albert M, O'Brien RJ. Cerebrospinal fluid Aβ and tau level fluctuation in an older clinical cohort. Archives Neurology. 2012;69(2):246-50. DOI: 10.1001/archneurol.2011.732. PubMed PMID: 22332192; PubMed Central PMCID: PMC3310240.

Mediterranean diet and white matter hyperintensity volume in the Northern Manhattan Study.

Gardener H, Scarmeas N, Gu Y, Boden-Albala B, Elkind MSV, Sacco RL, et al. Mediterranean diet and white matter hyperintensity volume in the Northern Manhattan Study. Archives Neurology. 2012;69(2):251-6. DOI: 10.1001/archneurol.2011.548. PubMed PMID: 22332193; PubMed Central PMCID: PMC3281550.

Identifying subtle cortical gyral abnormalities as a predictor of focal cortical dysplasia and a cure for epilepsy.

Oster JM, Igbokwe E, Cosgrove GR, Cole AJ. Identifying subtle cortical gyral abnormalities as a predictor of focal cortical dysplasia and a cure for epilepsy. Archives Neurology. 2012;69(2):257-61. DOI: 10.1001/archneurol.2011.1002. PubMed PMID: 21987396.

Rebound of disease activity after withdrawal of fingolimod (FTY720) treatment.

Havla JB, Pellkofer HL, Meinl I, Gerdes LA, Hohlfeld R, Kümpfel T. Rebound of disease activity after withdrawal of fingolimod (FTY720) treatment. Archives Neurology. 2012;69(2):262-4. DOI: 10.1001/archneurol.2011.1057. PubMed PMID: 22332194.

Peripheral nerve toxic effects of nitrofurantoin.

Tan IL, Polydefkis MJ, Ebenezer GJ, Hauer P, McArthur JC. Peripheral nerve toxic effects of nitrofurantoin. Archives Neurology. 2012;69(2):265-8. DOI: 10.1001/archneurol.2011.1120. PubMed PMID: 22332195.

Pattern classification of volitional functional magnetic resonance imaging responses in patients with severe brain injury.

Bardin JC, Schiff ND, Voss HU. Pattern classification of volitional functional magnetic resonance imaging responses in patients with severe brain injury. Archives Neurology. 2012;69(2):176-81. DOI: 10.1001/archneurol.2011.892. PubMed PMID: 22332186.

Association between immediate initiation of intramuscular interferon beta-1a at the time of a clinically isolated syndrome and long-term outcomes: a 10-year follow-up of the Controlled High-Risk Avonex Multiple Sclerosis Prevention Study in Ongoing Neurol

Kinkel RP, Dontchev M, Kollman C, Skaramagas TT, O'Connor PW, Simon JH. Association between immediate initiation of intramuscular interferon beta-1a at the time of a clinically isolated syndrome and long-term outcomes: a 10-year follow-up of the Controlled High-Risk Avonex Multiple Sclerosis Prevention Study in Ongoing Neurol. Archives Neurology. 2012;69(2):183-90. DOI: 10.1001/archneurol.2011.1426. PubMed PMID: 21987393.

Immunological markers of optimal response to natalizumab in multiple sclerosis.

Villar LM, García-Sánchez MI, Costa-Frossard L, Espiño M, Roldán E, Páramo D, et al.. Immunological markers of optimal response to natalizumab in multiple sclerosis. Archives Neurology. 2012;69(2):191-7. DOI: 10.1001/archneurol.2011.971. PubMed PMID: 22332187.

Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab.

Ostrowitzki S, Deptula D, Thurfjell L, Barkhof F, Bohrmann B, Brooks DJ, et al. Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab. Archives Neurology. 2012;69(2):198-207. DOI: 10.1001/archneurol.2011.1538. PubMed PMID: 21987394.